Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.

about

Clinical Implications of iNOS Levels in Triple-Negative Breast Cancer Responding to Neoadjuvant Chemotherapy.

Item

http://www.wikidata.org/entity/Q35701943

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@ast

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@en

type

Item

label

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@ast

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@en

prefLabel

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@ast

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@en

P1476

Clinical Implications of iNOS ...... g to Neoadjuvant Chemotherapy.

@en

P2093

Bo Chen

http://www.w3.org/2001/XMLSchema#string

Cheng Liu

http://www.w3.org/2001/XMLSchema#string

Feng Jin

http://www.w3.org/2001/XMLSchema#string

Guanglei Chen

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Liang Wei

http://www.w3.org/2001/XMLSchema#string

Nan Jiang

http://www.w3.org/2001/XMLSchema#string

Shouliang Cai

http://www.w3.org/2001/XMLSchema#string

Xiaoyin Xu

http://www.w3.org/2001/XMLSchema#string

Xuhong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic treatment strategies for triple-negative breast cancer.

Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin

Hallmarks of 'BRCAness' in sporadic cancers

Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.

Triple-negative breast cancer: clinical features and patterns of recurrence.

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin.

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

P304

e0130286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0130286

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wenqian Wang

P577

2015-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281820992

http://www.w3.org/2001/XMLSchema#string

P698

26196284

http://www.w3.org/2001/XMLSchema#string

P932

4510059

http://www.w3.org/2001/XMLSchema#string